Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages

Jana J. Von Lindern, Daniel Rojo, Kathie Grovit-Ferbas, Christine Yeramian, Cheng Deng, Georges Herbein, Monique Ferguson, Todd C. Pappas, Julie M. Decker, Anjali Singh, Ronald G. Collman, William A. O'Brien

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Macrophages and CD4+ lymphocytes are the principal target cells for human immunodeficiency virus type 1 (HIV-1) infection, but the molecular details of infection may differ between these cell types. During studies to identify cellular molecules that could be involved in macrophage infection, we observed inhibition of HIV-1 infection of macrophages by monoclonal antibody (MAb) to the tetraspan transmembrane glycoprotein CD63. Pretreatment of primary macrophages with anti-CD63 MAb, but not MAbs to other macrophage cell surface tetraspanins (CD9, CD81, and CD82), was shown to inhibit infection by several R5 and dualtropic strains, but not by X4 isolates. The block to productive infection was postfusion, as assessed by macrophage cell-cell fusion assays, but was prior to reverse transcription, as determined by quantitative PCR assay for new viral DNA formation. The inhibitory effects of anti-CD63 in primary macrophages could not be explained by changes in the levels of CD4, CCR5, or β-chemokines. Infections of peripheral blood lymphocytes and certain cell lines were unaffected by treatment with anti-CD63, suggesting that the role of CD63 in HIV-1 infection may be specific for macrophages.

Original languageEnglish (US)
Pages (from-to)3624-3633
Number of pages10
JournalJournal of Virology
Volume77
Issue number6
DOIs
StatePublished - Mar 2003

Fingerprint

Virus Diseases
Human immunodeficiency virus 1
HIV-1
macrophages
Macrophages
infection
Infection
monoclonal antibodies
Tetraspanins
lymphocytes
Monoclonal Antibodies
cells
Lymphocytes
cell fusion
reverse transcription
Cell Fusion
Viral DNA
assays
chemokines
Chemokines

ASJC Scopus subject areas

  • Immunology

Cite this

Von Lindern, J. J., Rojo, D., Grovit-Ferbas, K., Yeramian, C., Deng, C., Herbein, G., ... O'Brien, W. A. (2003). Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. Journal of Virology, 77(6), 3624-3633. https://doi.org/10.1128/JVI.77.6.3624-3633.2003

Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. / Von Lindern, Jana J.; Rojo, Daniel; Grovit-Ferbas, Kathie; Yeramian, Christine; Deng, Cheng; Herbein, Georges; Ferguson, Monique; Pappas, Todd C.; Decker, Julie M.; Singh, Anjali; Collman, Ronald G.; O'Brien, William A.

In: Journal of Virology, Vol. 77, No. 6, 03.2003, p. 3624-3633.

Research output: Contribution to journalArticle

Von Lindern, JJ, Rojo, D, Grovit-Ferbas, K, Yeramian, C, Deng, C, Herbein, G, Ferguson, M, Pappas, TC, Decker, JM, Singh, A, Collman, RG & O'Brien, WA 2003, 'Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages', Journal of Virology, vol. 77, no. 6, pp. 3624-3633. https://doi.org/10.1128/JVI.77.6.3624-3633.2003
Von Lindern, Jana J. ; Rojo, Daniel ; Grovit-Ferbas, Kathie ; Yeramian, Christine ; Deng, Cheng ; Herbein, Georges ; Ferguson, Monique ; Pappas, Todd C. ; Decker, Julie M. ; Singh, Anjali ; Collman, Ronald G. ; O'Brien, William A. / Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. In: Journal of Virology. 2003 ; Vol. 77, No. 6. pp. 3624-3633.
@article{1758dd98d25a44189b34893364e01310,
title = "Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages",
abstract = "Macrophages and CD4+ lymphocytes are the principal target cells for human immunodeficiency virus type 1 (HIV-1) infection, but the molecular details of infection may differ between these cell types. During studies to identify cellular molecules that could be involved in macrophage infection, we observed inhibition of HIV-1 infection of macrophages by monoclonal antibody (MAb) to the tetraspan transmembrane glycoprotein CD63. Pretreatment of primary macrophages with anti-CD63 MAb, but not MAbs to other macrophage cell surface tetraspanins (CD9, CD81, and CD82), was shown to inhibit infection by several R5 and dualtropic strains, but not by X4 isolates. The block to productive infection was postfusion, as assessed by macrophage cell-cell fusion assays, but was prior to reverse transcription, as determined by quantitative PCR assay for new viral DNA formation. The inhibitory effects of anti-CD63 in primary macrophages could not be explained by changes in the levels of CD4, CCR5, or β-chemokines. Infections of peripheral blood lymphocytes and certain cell lines were unaffected by treatment with anti-CD63, suggesting that the role of CD63 in HIV-1 infection may be specific for macrophages.",
author = "{Von Lindern}, {Jana J.} and Daniel Rojo and Kathie Grovit-Ferbas and Christine Yeramian and Cheng Deng and Georges Herbein and Monique Ferguson and Pappas, {Todd C.} and Decker, {Julie M.} and Anjali Singh and Collman, {Ronald G.} and O'Brien, {William A.}",
year = "2003",
month = "3",
doi = "10.1128/JVI.77.6.3624-3633.2003",
language = "English (US)",
volume = "77",
pages = "3624--3633",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages

AU - Von Lindern, Jana J.

AU - Rojo, Daniel

AU - Grovit-Ferbas, Kathie

AU - Yeramian, Christine

AU - Deng, Cheng

AU - Herbein, Georges

AU - Ferguson, Monique

AU - Pappas, Todd C.

AU - Decker, Julie M.

AU - Singh, Anjali

AU - Collman, Ronald G.

AU - O'Brien, William A.

PY - 2003/3

Y1 - 2003/3

N2 - Macrophages and CD4+ lymphocytes are the principal target cells for human immunodeficiency virus type 1 (HIV-1) infection, but the molecular details of infection may differ between these cell types. During studies to identify cellular molecules that could be involved in macrophage infection, we observed inhibition of HIV-1 infection of macrophages by monoclonal antibody (MAb) to the tetraspan transmembrane glycoprotein CD63. Pretreatment of primary macrophages with anti-CD63 MAb, but not MAbs to other macrophage cell surface tetraspanins (CD9, CD81, and CD82), was shown to inhibit infection by several R5 and dualtropic strains, but not by X4 isolates. The block to productive infection was postfusion, as assessed by macrophage cell-cell fusion assays, but was prior to reverse transcription, as determined by quantitative PCR assay for new viral DNA formation. The inhibitory effects of anti-CD63 in primary macrophages could not be explained by changes in the levels of CD4, CCR5, or β-chemokines. Infections of peripheral blood lymphocytes and certain cell lines were unaffected by treatment with anti-CD63, suggesting that the role of CD63 in HIV-1 infection may be specific for macrophages.

AB - Macrophages and CD4+ lymphocytes are the principal target cells for human immunodeficiency virus type 1 (HIV-1) infection, but the molecular details of infection may differ between these cell types. During studies to identify cellular molecules that could be involved in macrophage infection, we observed inhibition of HIV-1 infection of macrophages by monoclonal antibody (MAb) to the tetraspan transmembrane glycoprotein CD63. Pretreatment of primary macrophages with anti-CD63 MAb, but not MAbs to other macrophage cell surface tetraspanins (CD9, CD81, and CD82), was shown to inhibit infection by several R5 and dualtropic strains, but not by X4 isolates. The block to productive infection was postfusion, as assessed by macrophage cell-cell fusion assays, but was prior to reverse transcription, as determined by quantitative PCR assay for new viral DNA formation. The inhibitory effects of anti-CD63 in primary macrophages could not be explained by changes in the levels of CD4, CCR5, or β-chemokines. Infections of peripheral blood lymphocytes and certain cell lines were unaffected by treatment with anti-CD63, suggesting that the role of CD63 in HIV-1 infection may be specific for macrophages.

UR - http://www.scopus.com/inward/record.url?scp=0037333915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037333915&partnerID=8YFLogxK

U2 - 10.1128/JVI.77.6.3624-3633.2003

DO - 10.1128/JVI.77.6.3624-3633.2003

M3 - Article

C2 - 12610138

AN - SCOPUS:0037333915

VL - 77

SP - 3624

EP - 3633

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

ER -